Cardiovascular endocrinology has entered a period of rapid expansion, driven by advances in molecular profiling, translational therapeutics, and integrative ...

Rising NEC Incidence: The global increase in diagnosed cases of neuroendocrine tumors (including carcinomas) is a major market growth driver. This uptick is driven by better detection and reporting, ...

What should oncology nurses and advanced practice providers understand about GLP-1 RAs in the care of patients with breast ...

(Kobe University) Palm reading may not foresee your future, but if you flip your hand around, it could reveal crucial information about how long you may live. According to new research, a simple photo ...

The distributed control systems (DCS) market is projected to grow significantly, reaching an estimated value of $33.63 ...

A 2026 industry overview of the Direct Meds telehealth platform, including its compounded GLP-1 medication access model, pricing structure, delivery formats, consultation process, pharmacy sourcing, ...

Roche Holdings AG RHHBY on Monday shared results from the phase 3 persevERA Breast Cancer study of giredestrant combined with palbociclib in advanced cancer patients. Trial Misses Primary Goal The ...

So welcome to our second IR went in 2026, focusing this time on the Phase III ALLEGORY results for Gazyva in SLE, which just got presented last Friday at SLEuro. Today's call is scheduled for 60 ...

Researchers from the University of Southern Denmark investigated how eight weeks of high-intensity interval training affect the structure of mitochondria—the parts of muscle cells that produce energy.

A 2026 informational consumer research report examining the TMates telehealth weight-loss platform, compounded GLP-1 ...

The neuroendocrine carcinoma market is experiencing steady growth driven by rising disease prevalence and improved diagnostic capabilities. Advancements in targeted therapies and immunotherapies ...